Vasospastic Syndrome Clinical Trial
Official title:
The Effect of Triflusal on Peripheral Microcirculation Dysfunction: A Double-Blind, Randomized, Controlled, Crossover Study.
To explore the efficacy of triflusal in patients with symptomatic peripheral microcirculation dysfunction. Triflusal is a salicylate compound approved in several countries as antithrombotic agent and it additionally has vasodilatory effect. The hypothesis is to explore if there is a improvement of peripheral microcirculation by triflusal.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00409123 -
Effect of Systemic Cooling in Vasospasms
|
N/A | |
| Completed |
NCT00319371 -
Registration of Skin-Temperatures and Sleep-Wake Behaviour
|
N/A | |
| Completed |
NCT00675181 -
Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow
|
N/A |